These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32199889)

  • 21. Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.
    Georgakopoulos JR; Mufti A; Vender R; Yeung J
    J Am Acad Dermatol; 2020 Oct; 83(4):1212-1214. PubMed ID: 32679279
    [No Abstract]   [Full Text] [Related]  

  • 22. Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity.
    Shanshal M
    J Dermatolog Treat; 2020 Jun; 31(4):322-323. PubMed ID: 32255383
    [No Abstract]   [Full Text] [Related]  

  • 23. Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto.
    Georgakopoulos JR; Yeung J
    J Cutan Med Surg; 2020; 24(4):424-425. PubMed ID: 32475151
    [No Abstract]   [Full Text] [Related]  

  • 24. Myocarditis in the era of SARS-CoV-2: one piece of a complex puzzle?
    Polito MV; Ravera A
    Herz; 2020 Aug; 45(5):458-460. PubMed ID: 32514586
    [No Abstract]   [Full Text] [Related]  

  • 25. Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.
    Armesto S; González Vela C; González López MA
    Dermatol Ther; 2020 Jul; 33(4):e13618. PubMed ID: 32424891
    [No Abstract]   [Full Text] [Related]  

  • 26. Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.
    Megna M; Ruggiero A; Marasca C; Fabbrocini G
    J Dermatolog Treat; 2020 Jun; 31(4):328-329. PubMed ID: 32301363
    [No Abstract]   [Full Text] [Related]  

  • 27. Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
    He YC; Chen F
    Emerg Infect Dis; 2020 Sep; 26(9):2297-2298. PubMed ID: 32818421
    [No Abstract]   [Full Text] [Related]  

  • 28. Consensus on STEMI Management in the Era of COVID-19.
    Chopra HK; Hiremath SM; Wander GS; Kumar AS; Naik S
    J Assoc Physicians India; 2020 Aug; 68(8):76-81. PubMed ID: 32738846
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.
    Conforti C; Giuffrida R; Dianzani C; Di Meo N; Zalaudek I
    Dermatol Ther; 2020 Jul; 33(4):e13298. PubMed ID: 32157783
    [No Abstract]   [Full Text] [Related]  

  • 30. Endourological Stone Management in the Era of the COVID-19.
    Proietti S; Gaboardi F; Giusti G
    Eur Urol; 2020 Aug; 78(2):131-133. PubMed ID: 32303384
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19, a viral endocrinological disease?
    Grassi T; Varotto E; Galassi FM
    Eur J Intern Med; 2020 Jul; 77():156-157. PubMed ID: 32571582
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 and pulmonary rehabilitation: preparing for phase three.
    Polastri M; Nava S; Clini E; Vitacca M; Gosselink R
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32586841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maxillofacial services in the COVID-19 (SARS-CoV-2) pandemic - early lessons from the Italian experience.
    Riva FMG; Kerawala C
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):744-745. PubMed ID: 32576462
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacist-driven education for solid organ transplant recipients in the COVID-19 era.
    Fan A; Kamath M
    Clin Transplant; 2020 Aug; 34(8):e14013. PubMed ID: 32578893
    [No Abstract]   [Full Text] [Related]  

  • 35. Anosmia and loss of smell in the era of covid-19.
    Walker A; Pottinger G; Scott A; Hopkins C
    BMJ; 2020 Jul; 370():m2808. PubMed ID: 32694187
    [No Abstract]   [Full Text] [Related]  

  • 36. Dermatologic surgery training during the COVID-19 era.
    García-Lozano JA; Cuellar-Barboza A; Garza-Rodríguez V; Vázquez-Martínez O; Ocampo-Candiani J
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e370-e372. PubMed ID: 32386437
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19 and immunomodulator/immunosuppressant use in dermatology.
    Price KN; Frew JW; Hsiao JL; Shi VY
    J Am Acad Dermatol; 2020 May; 82(5):e173-e175. PubMed ID: 32224277
    [No Abstract]   [Full Text] [Related]  

  • 38. Heart Failure Editorial Emergencies in the COVID-19 Era.
    O'Connor CM
    JACC Heart Fail; 2020 Jun; 8(6):518. PubMed ID: 32466838
    [No Abstract]   [Full Text] [Related]  

  • 39. How to face cancer treatment in the COVID-19 era.
    Brandes AA; Di Nunno V
    Expert Rev Anticancer Ther; 2020 Jun; 20(6):429-432. PubMed ID: 32370563
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 complications in children.
    Baron M; Sherwen O; Heaton PA; Paul SP
    Br J Nurs; 2020 Nov; 29(20):1146. PubMed ID: 33180606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.